Seeking Alpha

CNAT
  Conatus Pharmaceuticals - NASDAQ

9/23/2014, 1:25 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
CNAT vs. ETF Alternatives
Company Description
Conatus Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease.
Sector: Healthcare
Industry: Biotechnology
Country: United States